Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
3.230
+0.360 (12.54%)
At close: Nov 16, 2026, 4:00 PM EST
3.141
-0.089 (-2.76%)
After-hours: Nov 16, 2026, 7:59 PM EST

Lexeo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
267725218358--
Market Cap Growth
-59.47%233.00%-39.13%---
Enterprise Value
7961071523--
Last Close Price
3.239.936.5813.42--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.232.941.863.15--
P/TBV Ratio
1.232.941.863.15--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.030.090.100.19-
Net Debt / Equity Ratio
-0.87-0.70-0.95-0.97-0.89-1.05
Net Debt / EBITDA Ratio
1.671.601.061.621.062.68
Net Debt / FCF Ratio
2.151.761.371.841.163.06
Asset Turnover
----0.010.02
Quick Ratio
8.3210.815.327.055.3918.24
Current Ratio
8.6911.215.527.215.5818.35
Return on Equity (ROE)
-62.39%-55.00%-85.37%-71.54%-58.84%-65.27%
Return on Assets (ROA)
-36.71%-32.86%-46.11%-36.15%-32.33%-38.07%
Return on Capital Employed (ROCE)
-51.70%-43.40%-85.20%-55.90%-73.10%-39.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-39.25%-13.79%-45.18%-18.57%--
FCF Yield
-32.81%-13.65%-37.51%-16.67%--
Buyback Yield / Dilution
-94.19%-68.76%-493.67%-228.42%-5.00%-7.72%
SEC Filings: 10-K · 10-Q